Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Efficacy and safety of oral small molecule glucagon-like peptide 1 receptor agonist danuglipron for glycemic control among patients with type 2 diabetes: a randomized clinical trial
Data from a global phase 1/2 clinical trial (NCT03812263) that showed a 100% overall survival rate in all enrolled patients for at least 1 year post treatment, and through the entire duration of follow-up, support the BLA
MOTS-c is one of the most interesting mitochondrial peptides in 2026 because the question is finally shifting from mechanism to human outcomes
Currently, there is not enough high-quality clinical evidence to support the use of BPC-157 for weight management or fat loss in humans
US$ 24.97
US$ 22.11
US$ 27.00
US$ 28.90
US$ 24.85
US$ 22.51
US$ 20.78
